F

Fortress Biotech
D

FBIOP

5.22000
USD
-0.06
(-1.14%)
Market Open
Volume
200
EPS
0
Div Yield
33.93
P/E
0
Market Cap
17,889,660
News

Title: Fortress Biotech

Sector: Healthcare
Industry: Biotechnology
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq,Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.